Gary Lieberman analyst CAPITAL ONE

Currently out of the existing stock ratings of Gary Lieberman, 6 are a HOLD (60%), 2 are a SELL (20%), 2 are a BUY (20%).

Gary Lieberman

Work Performance Price Targets & Ratings Chart

Analyst Gary Lieberman, currently employed at CAPITAL ONE, carries an average stock price target met ratio of 100% that have a potential upside of 2.38% achieved within 52 days. Previously, Gary Lieberman worked at WELLS FARGO.

Gary Lieberman’s has documented 13 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on DGX, Quest Diagnostics at 20-Oct-2017.

Wall Street Analyst Gary Lieberman

Analyst best performing recommendations are on DGX (QUEST DIAGNOSTICS).
The best stock recommendation documented was for DGX (QUEST DIAGNOSTICS) at 10/12/2017. The price target of $88 was fulfilled within 49 days with a profit of $6.07 (7.41%) receiving and performance score of 1.51.

Average potential price target upside

DGX Quest Diagnostics THC Tenet Healthcare

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$200

$22.05 (12.39%)

$180

12 days ago
(28-Apr-2025)

5/7 (71.43%)

$23.32 (13.20%)

196

Buy

$194

$16.05 (9.02%)

$191

17 days ago
(23-Apr-2025)

23/26 (88.46%)

$20.43 (11.77%)

336

Hold

$180

$2.05 (1.15%)

$165

17 days ago
(23-Apr-2025)

4/5 (80%)

$6.43 (3.70%)

252

Hold

$190

$12.05 (6.77%)

$182

17 days ago
(23-Apr-2025)

15/17 (88.24%)

$16.43 (9.47%)

397

Buy

$189

$11.05 (6.21%)

$178

1 months 1 days ago
(09-Apr-2025)

21/23 (91.3%)

$24.94 (15.20%)

482

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Gary Lieberman?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?